Global Cord Blood (NYSE:CO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO) in a research report sent to investors on Thursday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Global Cord Blood stock remained flat at $1.25 during trading hours on Thursday. The company’s stock had a trading volume of 36,719 shares, compared to its average volume of 216,519. Global Cord Blood has a 1-year low of $2.03 and a 1-year high of $5.50. The stock has a 50-day simple moving average of $1.55 and a 200-day simple moving average of $1.39. The stock has a market cap of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.